Promotion of Cell Death in Cisplatin-Resistant Ovarian Cancer Cells through KDM1B-DCLRE1B Modulation

Promotion of Cell Death in Cisplatin-Resistant Ovarian Cancer Cells through KDM1B-DCLRE1B Modulation

Ovarian cancer is the gynecological malignancy with the poorest prognosis, in part due to its high incidence of recurrence. Platinum agents are widely used as a first-line treatment against ovarian cancer. Recurrent tumors, however, frequently demonstrate acquired chemo-resistance to platinum agent...

Full description

Bibliographic Details
Main Authors: Yeon Kyu Lee, Jinyeong Lim, So Young Yoon, Jong Cheon Joo, Soo Jung Park, Yoon Jung Park
Format: Article
Language:English
Published: MDPI AG 2019-05-01
Series:International Journal of Molecular Sciences
Subjects:
ovarian cancer
<i>Oldenlandia diffusa</i>
cisplatin
cell death
KDM1B
DCLRE1B
Online Access:https://www.mdpi.com/1422-0067/20/10/2443

Internet

https://www.mdpi.com/1422-0067/20/10/2443

Similar Items